In vitro diagnostics company bioMérieux, Inc., has announced that EMSL Analytical, provider of microbiology testing specializing in rapid pathogen detection, is adopting the company’s VITEK MS technology for rapid identification of potentially harmful microorganisms. VITEK MS uses MALDI-TOF mass spectrometry technology to identify bacteria, yeast, and mold. The system received de novo FDA clearance for IVD last August.
“We are excited to bring this state of the art technology to EMSL. The VITEK MS gives us the ability to provide microbial identification with unprecedented speed and accuracy for our clients. VITEK MS also aligns with the needs of EMSL’s cGMP Microbiology lab as well as environmental and forensic microbiological capabilities. We look forward to providing our clients with the benefits that the VITEK MS brings,” says Peter Frasca, PhD, President of EMSL LABS.
“Reference laboratories today are striving to improve productivity and shorten the time-to-results needed by their customers,” says Pierre-Louis Thiney, Executive Director, U.S. Industry, for bioMérieux. “Providing a fully integrated, rapid solution for microbial identification is a significant step in providing timely and accurate results to the customer.” Learn more about VITEK MS at the bioMerieux website.
